Kiora Pharmaceuticals Future Growth
Future criteria checks 0/6
Kiora Pharmaceuticals's revenue and earnings are forecast to decline at 15.7% and 35.4% per annum respectively while EPS is expected to decline by 39.5% per annum.
Key information
-35.4%
Earnings growth rate
-39.5%
EPS growth rate
Pharmaceuticals earnings growth | 27.6% |
Revenue growth rate | -15.7% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 20 May 2024 |
Recent future growth updates
Recent updates
Why Kiora Pharmaceuticals' (NASDAQ:KPRX) Earnings Are Better Than They Seem
May 21Kiora pharmaceuticals regains compliance with Nasdaq minimum bid price requirement
Oct 13Kiora Pharma announces 1-for-40 reverse stock split
Sep 26Kiora Pharmaceuticals reports 1H results
Aug 12Kiora gets US patent for KIO-201 use with antibiotics for eye wound healing
Jul 28Kiora Pharmaceuticals prices $5.2M underwritten public offering
Jul 22Kiora begins enrolling in phase 2 trial of wound healing eye drops KIO-201
Jul 05EyeGate Pharmaceuticals announces $8M private placement
Jan 06EyeGate surge in premarket as it acquires Panoptes Pharma for $4M
Dec 21Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1 | -20 | N/A | N/A | 2 |
12/31/2025 | 2 | -14 | N/A | N/A | 3 |
12/31/2024 | 17 | 4 | N/A | N/A | 3 |
3/31/2024 | 16 | 2 | 7 | 7 | N/A |
12/31/2023 | N/A | -13 | -10 | -10 | N/A |
9/30/2023 | N/A | -13 | -9 | -9 | N/A |
6/30/2023 | N/A | -12 | -10 | -10 | N/A |
3/31/2023 | N/A | -12 | -11 | -11 | N/A |
12/31/2022 | N/A | -14 | -10 | -10 | N/A |
9/30/2022 | N/A | -17 | -11 | -11 | N/A |
6/30/2022 | N/A | -15 | -11 | -11 | N/A |
3/31/2022 | N/A | -15 | -11 | -11 | N/A |
12/31/2021 | N/A | -14 | -11 | -11 | N/A |
9/30/2021 | 0 | -9 | -10 | -9 | N/A |
6/30/2021 | 0 | -8 | -9 | -9 | N/A |
3/31/2021 | 0 | -7 | -8 | -7 | N/A |
12/31/2020 | 0 | -7 | -7 | -7 | N/A |
9/30/2020 | N/A | -8 | -8 | -8 | N/A |
6/30/2020 | N/A | -10 | -8 | -8 | N/A |
3/31/2020 | N/A | -10 | -8 | -8 | N/A |
12/31/2019 | 3 | -7 | -8 | -8 | N/A |
9/30/2019 | 3 | -7 | -8 | -8 | N/A |
6/30/2019 | 3 | -7 | -9 | -8 | N/A |
3/31/2019 | 3 | -8 | -9 | -9 | N/A |
12/31/2018 | 2 | -11 | -11 | -11 | N/A |
9/30/2018 | 2 | -11 | -11 | -10 | N/A |
6/30/2018 | 1 | -12 | -10 | -10 | N/A |
3/31/2018 | 1 | -13 | -11 | -11 | N/A |
12/31/2017 | 0 | -13 | N/A | -6 | N/A |
9/30/2017 | 1 | -14 | N/A | -7 | N/A |
6/30/2017 | 1 | -13 | N/A | -7 | N/A |
3/31/2017 | 1 | -14 | N/A | -7 | N/A |
12/31/2016 | 1 | -13 | N/A | -8 | N/A |
9/30/2016 | 1 | -12 | N/A | -8 | N/A |
6/30/2016 | 0 | -10 | N/A | -6 | N/A |
3/31/2016 | N/A | -8 | N/A | -4 | N/A |
12/31/2015 | N/A | -17 | N/A | -4 | N/A |
9/30/2015 | N/A | -14 | N/A | -3 | N/A |
6/30/2015 | N/A | -13 | N/A | -3 | N/A |
3/31/2015 | N/A | -12 | N/A | -2 | N/A |
12/31/2014 | N/A | -2 | N/A | -1 | N/A |
9/30/2014 | N/A | -2 | N/A | -1 | N/A |
6/30/2014 | N/A | -3 | N/A | -2 | N/A |
3/31/2014 | N/A | -4 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KPRX's earnings are forecast to decline over the next 3 years (-35.4% per year).
Earnings vs Market: KPRX's earnings are forecast to decline over the next 3 years (-35.4% per year).
High Growth Earnings: KPRX's earnings are forecast to decline over the next 3 years.
Revenue vs Market: KPRX's revenue is expected to decline over the next 3 years (-15.7% per year).
High Growth Revenue: KPRX's revenue is forecast to decline over the next 3 years (-15.7% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if KPRX's Return on Equity is forecast to be high in 3 years time